Rhonda Williams
Medical · Martinsburg, WVNPI 1194225904
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 414 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 18.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $2,570 and has fallen 86.1% since, to $357 in 2025. Among medical clinicians in WV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 414 payments — averaging $19.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Lilly USA, LLC$1K
- AstraZeneca$761
- Novo Nordisk$758
- GSK$650
- Pfizer$482
- plus $3K from 29 others
What the payments were for
- Food & beverage$8,18799%
- Education$651%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 81 | $1,555 |
| Lilly USA, LLC | 58 | $1,114 |
| AstraZeneca | 36 | $761 |
| Novo Nordisk | 38 | $758 |
| GSK | 20 | $650 |
| Pfizer | 29 | $482 |
| Boehringer Ingelheim | 28 | $436 |
| Astellas Pharma US Inc | 10 | $285 |
| Merck | 15 | $250 |
| Bayer | 12 | $235 |
| Novartis | 8 | $141 |
| Johnson & Johnson | 7 | $140 |
| Esperion Therapeutics, Inc. | 7 | $139 |
| Nestle Healthcare Nutrition Inc. | 3 | $127 |
| E.r. Squibb & Sons, L.L.C. | 3 | $124 |
| Otsuka America Pharmaceutical, Inc. | 8 | $117 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $110 |
| Amgen | 7 | $109 |
| Kowa Pharmaceuticals America, Inc. | 5 | $85 |
| Eisai Inc. | 4 | $80 |
| Sunovion Pharmaceuticals Inc. | 3 | $76 |
| Teva Pharmaceuticals USA, Inc. | 4 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $64 |
| Amarin Pharma, Inc. | 3 | $54 |
| Viiv Healthcare Company | 2 | $43 |
| Sumitomo Pharma America, Inc. | 2 | $42 |
| Hologic Sales And Service, LLC | 1 | $35 |
| Radius Health, Inc. | 2 | $34 |
| Phathom Pharmaceuticals, Inc. | 2 | $29 |
| Exact Sciences | 1 | $21 |
| Biogen | 1 | $20 |
| Biohaven Pharmaceuticals, Inc. | 1 | $19 |
| Seqirus USA Inc | 1 | $16 |
| Aimmune Therapeutics, Inc. | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,252 in reported general payments places this provider in the 95th percentile of 233 medical providers in West Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OtezlaApremilast | 11 | $63,172 |
| EliquisApixaban | 41 | $40,012 |
| TrulicityDulaglutide | 27 | $37,213 |
| JanuviaSitagliptin Phosphate | 28 | $32,999 |
| XareltoRivaroxaban | 21 | $18,089 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 18 | $15,206 |
| FarxigaDapagliflozin Propanediol | 20 | $12,616 |
| NamzaricMemantine Hcl/Donepezil Hcl | 12 | $8,880 |
| GlyxambiEmpagliflozin/Linagliptin | 13 | $7,974 |
| Omeprazole | 73 | $2,095 |
| Rosuvastatin Calcium | 95 | $1,661 |
| Levothyroxine Sodium | 179 | $1,341 |
| Sertraline Hcl | 107 | $1,240 |
| Fenofibrate | 21 | $1,231 |
| Metoprolol Succinate | 68 | $1,082 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenOtezla | $109 | $63,17211 claims |
| PfizerEliquis | $482 | $40,01241 claims |
| Lilly USA, LLCTrulicity | $1,114 | $37,21327 claims |
| MerckJanuvia | $250 | $32,99928 claims |
| Johnson & JohnsonXarelto | $140 | $18,08921 claims |
| GSKTrelegy Ellipta | $650 | $15,20618 claims |
| AstraZenecaFarxiga | $761 | $12,61620 claims |
| AbbVieNamzaric, Synthroid | $1,555 | $9,43942 claims |
| Boehringer IngelheimGlyxambi | $436 | $7,97413 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 233 medical providers in West Virginia.
Other medical in Martinsburg
- Denise PettitMartinsburg$6K
- Katherine BoggsSouth Charleston$46K
- Lowell LarewMorgantown$31K
- Katie CarpenterSouth Charleston$26K
- Lauren DillonBeckley$18K
- Angela HagerFarmington$16K
- Brandon CaragCharleston$16K
- Scott EthridgeCharleston$16K
- Kellie HanselSouth Charleston$12K
- Matthew MaynardElkins$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.